JPS58113755A - Production of artificial carrier - Google Patents

Production of artificial carrier

Info

Publication number
JPS58113755A
JPS58113755A JP20986981A JP20986981A JPS58113755A JP S58113755 A JPS58113755 A JP S58113755A JP 20986981 A JP20986981 A JP 20986981A JP 20986981 A JP20986981 A JP 20986981A JP S58113755 A JPS58113755 A JP S58113755A
Authority
JP
Japan
Prior art keywords
particles
carrier
gelatin
temp
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP20986981A
Other languages
Japanese (ja)
Other versions
JPS6332148B2 (en
Inventor
Mikio Ikeda
池田 幹雄
Takayuki Tomizawa
富沢 孝之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Priority to JP20986981A priority Critical patent/JPS58113755A/en
Priority to EP19820301235 priority patent/EP0062968B2/en
Publication of JPS58113755A publication Critical patent/JPS58113755A/en
Publication of JPS6332148B2 publication Critical patent/JPS6332148B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548Carbohydrates, e.g. dextran
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00Photosensitive materials
    • G03C1/005Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/04Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
    • G03C1/047Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
    • G03C2001/0471Isoelectric point of gelatine

Abstract

PURPOSE:To obtain a carrier which can be preserved for a long period of time by adjusting a soln. contg. gelatin, water soluble polysaccharides, sodium polymetaphosphate, as well as a hydrophilic org. solvent and water in a specific pH range by adding acids thereto to form particles then cooling the same to temp. lower than specific temp. and effecting crosslinking agents therewith. CONSTITUTION:Acids (acetic acid, etc.) are added to a soln. contg. gelatin, water soluble polysaccharides (gum arabic, etc.), sodium polymetaphosphate, and a hydrophilic org. solvent (alcohol, etc.) and water under stirring at temp. higher than the gelling temp. of the gelatin to adjust 2.5-6.0pH and to form a dispersion of gel particles. After the formation of the particles, the soln. is cooled and when the temp. thereof drops to <=10 deg.C, crosslinking agents (glutaraldehyde, CH3CHO, etc.) are added thereto to obtain crosslinked particles. The crosslinked particles are centrifugally separated and washed, whereby the carrier to be deposited thereon with antigens, etc. for serodiagnosis, etc. is obtained. This carrier is obtained in optional grain sizes according to production conditions, is good in yield, permits preservation for a long period of time and is usable anytime without liberation of antigens, etc. even when the carrier is bound with the antigens, etc. and is frozen and preserved.

Description

【発明の詳細な説明】 定などに広く利用しうる新規な人工担体の製法の改良に
関する。抗原、抗体反応を利用する臨床検査等の分野に
おいて、抗原または抗体をある適当な大きさの粒子を担
体としてそれに吸着もしくは′結合させ、それぞれに対
応する抗体または抗原の存在によってこの感作された担
体の凝集を起させる方法は間接受身凝集反応と呼ばれて
いる。そして、この間接受身凝集反応は被検液中の抗体
や抗原を高感度に検出できるので、いろいろの疾恵の血
清学的診断に広く用いられている。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an improvement in the production method of a novel artificial carrier that can be widely used in medicine, etc. In fields such as clinical tests that utilize antigen and antibody reactions, antigens or antibodies are adsorbed or bonded to particles of an appropriate size as carriers, and the presence of the corresponding antibodies or antigens induces sensitization. The method of causing aggregation of carriers is called indirect passive aggregation reaction. Since this indirect passive agglutination reaction can detect antibodies and antigens in a sample liquid with high sensitivity, it is widely used for serological diagnosis of various diseases.

この反応に用いられる担体としては、ポリスチレンラテ
ックス、カオリン、炭末などの非生物学的担体と、動物
赤血球、細薦菌体のような生物学的粒子とがある。一般
に非生物学的粒体の担体ハJヒ学的に安定で、それ自身
抗原活性を有しないなどの利点はあるが、抗原あるいは
抗.体が密に吸着されにくいという欠点がある。たとえ
ば、保存のために凍結乾燥すると抗原や抗体が担体から
遊離してしまうのである。そのために1やむなく液体中
で冷暗所に保存するという手段がとられているが、その
結果長期間保存することができない。また、非生物学的
担体のうち、炭末とカオリンは一定の大きさの粒子を選
出することが困難であり、ポリスチレンラテックスは反
応の媒質として望ましい中性域では非特異凝集である自
然凝集をおこす危険がある1゜ 一方、生物学的担体である動物赤血球や細菌菌体はそれ
ぞれの大きさが一定であるという利点はあるものの、生
物の種類によって粒子の大きさは定まっており、目的に
応じた任意の大きさの粒子を得ることはできない。たと
えば、動物赤血球は大きさの一定した最も入手しゃすい
担体であるが血球表面に固有の抗原を有しており、抗体
との間で非特異凝集反応である交差反応を起こして目的
とする凝集反応に誤まりを与える可能性がある。
Carriers used in this reaction include non-biological carriers such as polystyrene latex, kaolin, and charcoal powder, and biological particles such as animal red blood cells and bacterial cells. In general, non-biological particulate carriers have advantages such as being biologically stable and having no antigenic activity themselves; The drawback is that it is difficult for the body to be absorbed tightly. For example, when freeze-drying for storage, antigens and antibodies are released from the carrier. For this reason, it is unavoidable to store it in a liquid in a cool, dark place, but as a result, it cannot be stored for a long period of time. Furthermore, among non-biological carriers, it is difficult to select particles of a certain size for charcoal powder and kaolin, and polystyrene latex exhibits spontaneous aggregation, which is non-specific aggregation, in the neutral region, which is desirable as a reaction medium. On the other hand, although animal red blood cells and bacterial cells, which are biological carriers, have the advantage of having a fixed size, the size of the particles is fixed depending on the type of organism, and the size of the particles is determined according to the purpose. It is not possible to obtain particles of arbitrary size. For example, animal red blood cells are the most readily available carrier with a constant size, but they have unique antigens on the surface of the blood cells, and cross-react with antibodies, which is a non-specific agglutination reaction, resulting in the desired agglutination. This may lead to erroneous reactions.

さらに、赤血球の生物学的、化学的および物理的特性値
が動物の個体間でばら゛ついてしまって常に一定品質の
血球を入手することが難しいという欠点がある。
Furthermore, the biological, chemical, and physical properties of red blood cells vary among individual animals, making it difficult to obtain blood cells of constant quality.

本発明者らはこれらの欠点のないすぐれた担体を開発す
べく種々検討の結果、ゼラチン、水溶性多糖類、および
ポリメタリン酸ナトリウムを含み水とアルコール等の混
合物を溶媒とする溶液を攪拌下で一調整することによっ
て粒子を析出させ、この粒子をアルデヒド系架橋剤で処
理して不溶化すれば、従来の欠点を尽く解消したすぐれ
た相体が得られることを見出し、この内容を既に特許出
願した。この方法においては生成した粒子の凝集を防止
するために…調整後に界面活性剤を添加していたが、本
発明者らはその後さらに研究を進めた結果、酸の添加に
よって粒子が生成したのちに速かに冷却すれば界面活性
剤を添加しなくても界面活性剤を添加した場合に匹敵す
る好収率で担体粒子が得られることを見出し、これに基
いて本発明を完成するに到った。すなわち本発明は、ゼ
ラチン、水溶性多糖類、ポリメタリン酸ナトリウム、親
水性有機溶媒、および水を含み、温度がゼラチンのケ゛
ル化温度以上である溶液を、攪拌しつつ酸を加えてpH
2,5〜6.0に調整し、その後アルデヒド系架橋剤を
作用せしめて不溶化する人工担体の製法において、前記
酸の添加によって粒子が生成したのちこの粒子分散液を
10℃以下に冷却し、10℃以下の温度で前記架橋剤を
作用せしめることを特徴とする人工担体の製法に関する
ものである。
As a result of various studies in order to develop an excellent carrier that does not have these drawbacks, the present inventors prepared a solution containing gelatin, a water-soluble polysaccharide, and sodium polymetaphosphate in a mixture of water, alcohol, etc. as a solvent under stirring. We discovered that by precipitating particles through one adjustment, and insolubilizing these particles by treating them with an aldehyde-based crosslinking agent, we could obtain an excellent phase that eliminated all of the drawbacks of conventional methods, and we have already applied for a patent on this matter. . In this method, a surfactant was added after adjustment to prevent agglomeration of the generated particles, but as a result of further research by the present inventors, it was found that after the particles were generated by the addition of acid. It was discovered that by cooling quickly, carrier particles can be obtained without adding a surfactant at a good yield comparable to when a surfactant is added, and based on this finding, the present invention was completed. Ta. That is, in the present invention, a solution containing gelatin, a water-soluble polysaccharide, sodium polymetaphosphate, a hydrophilic organic solvent, and water and having a temperature equal to or higher than the gelatin temperature is adjusted to pH by adding an acid while stirring.
2.5 to 6.0, and then insolubilized by applying an aldehyde crosslinking agent, after particles are generated by adding the acid, the particle dispersion is cooled to 10 ° C. or less, The present invention relates to a method for producing an artificial carrier, characterized in that the crosslinking agent is allowed to act at a temperature of 10° C. or lower.

本発明に使用するゼラチンは通常は市販品をそのまま用
いればよい。市販品のなかでは酸性ゼラチンが好ましい
As the gelatin used in the present invention, commercially available gelatin may generally be used as is. Among commercially available products, acidic gelatin is preferred.

水溶性多糖類は増粘剤または糊料として使用しうるもの
であり、多糖類の誘導体および塩も含まれる。例として
は、アラビアゴム、カル〆キシメチルセルロース、アル
ギン酸ナトリウム、寒天、カラグーナンなどを挙げるこ
とができるが、特にアラビアゴムが好適である。
Water-soluble polysaccharides can be used as thickeners or thickeners, and also include derivatives and salts of polysaccharides. Examples include gum arabic, carboxymethyl cellulose, sodium alginate, agar, carrageenan, etc., with gum arabic being particularly preferred.

ポリメタリン酸プトリウムは化学式(Na PO3)n
で表わされる物質でありまたとえば四メタリン酸ナトリ
ウム、ヘキサメタリン酸ナトリウムの如きものである。
Polymetaphosphate puttrium has the chemical formula (Na PO3)n
Examples of such substances include sodium tetrametaphosphate and sodium hexametaphosphate.

親水性有機溶媒としては、低級アルコール、たトエばメ
チルアルコール、エチルアルコール、フロビルアルコー
ル等、およびアセトンなどを用いることができる。
As the hydrophilic organic solvent, lower alcohols, methyl alcohol, ethyl alcohol, flobyl alcohol, and acetone can be used.

そのほかのものとしては、担体を着色する場合には、着
色剤を粒子形成前に溶液に加えておくのがよい。着色を
必要とする例としては、本発明品を間接受身凝集反応の
担体として用いる場合を挙げることができる。すなわち
、本発明品は通常は無色不透明であるところから、これ
を着色することによって凝集像の判定を容易にすること
ができる。着色剤としては、た゛とえは食用赤色3号、
ローダミン、ローズペンがル、ポンソー3R1?ルドー
81フクシン、エオシン、およびニュートラルレッドな
どの赤色色素、あるいはクリスタルバイオレット、トル
イノ/ブルーおよびメチレンブルーなどの青色色素等を
用いつる。しかしながら、リアクティブ・レッド、ダイ
レクト・ブルーなどの反応性染料で着色すれば色落ちし
ないことから、反応性染料が特に好適である。着色剤以
外にも目的に応じ種々の物質を添加してもよいことはい
うまでもない。
Alternatively, if the carrier is to be colored, a coloring agent may be added to the solution before particle formation. An example where coloring is required is when the product of the present invention is used as a carrier for an indirect passive aggregation reaction. That is, since the product of the present invention is normally colorless and opaque, by coloring it, the agglomerated image can be easily determined. As a coloring agent, food red No. 3,
Rhodamine, Rose Pen, Ponceau 3R1? Red dyes such as Ludo 81 fuchsin, eosin, and neutral red, or blue dyes such as crystal violet, toluino/blue and methylene blue, etc. can be used. However, reactive dyes such as Reactive Red and Direct Blue do not cause color fading, so reactive dyes are particularly suitable. It goes without saying that in addition to the coloring agent, various substances may be added depending on the purpose.

一調整前の溶液におけるこれら各物質の濃度としては、
ゼラブ10.01〜2チ程度、好ましくは0.05〜1
.0チ程度、水溶性多糖−0,01〜2fi程度、好ま
しくは0.05〜t、ol程度、そして親水性有機溶媒
紘4〜25容量−程度である。/IJメタリン酸ナトリ
ウムはゼラチン乾燥重量の3〜15チ程度を含有させる
ようにするのがよい。各物質はこれらの濃度範囲におい
て、所望の粒子の粒径および物性に応じて適宜定めれば
よい。着色剤を添加する場合には、通常は0005〜0
.5%程度であるが、反応性染料を用いればゼラチン乾
燥重量の1〜5%程度で足りる。
The concentration of each of these substances in the solution before adjustment is as follows:
Zelab 10.01 to 2 inches, preferably 0.05 to 1
.. The volume of the water-soluble polysaccharide is about 0.01 to 2 fi, preferably about 0.05 to t, ol, and the volume of the hydrophilic organic solvent is about 4 to 25. /IJ Sodium metaphosphate should preferably be contained in an amount of about 3 to 15 g of the dry weight of gelatin. Each substance may be appropriately determined within these concentration ranges depending on the particle size and physical properties of the desired particles. When adding a colorant, it is usually 0005 to 0.
.. The amount is about 5%, but if a reactive dye is used, about 1 to 5% of the dry weight of gelatin is sufficient.

このような溶液を調製する過程は問うところではなく、
例えば各々を温水に溶解してから混合してもよく、各々
を一緒に溶解してもよい。しかしながら、各物質の溶解
を容易にするために親水性有機溶媒はあとから加えるの
がよく、また水溶性多糖類には不溶成分も少量含まれて
いることが多いところから、別途に溶解して添加するの
がよい、。
The process of preparing such a solution is not in question;
For example, each may be dissolved in warm water and then mixed, or each may be dissolved together. However, in order to facilitate the dissolution of each substance, it is best to add a hydrophilic organic solvent later, and since water-soluble polysaccharides often contain small amounts of insoluble components, they must be dissolved separately. It is good to add.

一方、ゼラチンは等電点以下の−では水溶性多糖類と反
応して白濁を生ずるので酸性ゼラチンを用□、。
On the other hand, when gelatin is below its isoelectric point, it reacts with water-soluble polysaccharides and becomes cloudy, so acidic gelatin is used.

いる場合にはアルカリを加えて溶液の−を少々くともそ
の付近にまで高めておくのがよい。しかしながら、この
白濁は生じた後でもアルカリを添加することによって消
すことができる。いずれにせよ、溶液は酸の添加を開始
するまえには白濁のない状態にして番かなければならな
い。
If there is, it is a good idea to add an alkali to raise the - level of the solution to at least that level. However, even after this cloudiness occurs, it can be eliminated by adding an alkali. In any case, the solution must be free from cloudiness before the acid addition begins.

溶液の温度はゼラチンのrル化温度以上でなければなら
ない。この温度はゼラチンの濃度等によって異なるが通
例25〜30℃程度である。良好な粒子形成の観点から
特に35〜50℃程度がよい。
The temperature of the solution must be above the gelatin's gelatinization temperature. This temperature varies depending on the concentration of gelatin, etc., but is usually about 25 to 30°C. From the viewpoint of good particle formation, the temperature is particularly preferably about 35 to 50°C.

次に、この溶液を攪拌しながら酸を加えて−2,5〜6
.0に調整する。この工程は粒子を生成させるところで
ある。均一な粒子を形成させるために、35〜50℃に
加温を続け、適度に攪拌しながら酸を滴下していくのが
よい。pH2,5〜6.0の範囲における至適のpHは
原料溶液の組成および目的とする粒径によって異なるの
でイめ実験を行なって定めるのがよい。たとえば得られ
た粒子を抗原感作用担体に用いる場合には2〜10μ程
度の□。
Next, add acid to this solution while stirring and add -2,5 to 6
.. Adjust to 0. This step is where particles are generated. In order to form uniform particles, it is preferable to continue heating at 35 to 50°C and drop the acid while stirring moderately. The optimum pH within the range of pH 2.5 to 6.0 varies depending on the composition of the raw material solution and the intended particle size, and is therefore preferably determined by conducting experiments. For example, when the obtained particles are used as an antigen-sensitizing carrier, the square size is about 2 to 10μ.

粒径にするのがよく、その場合至適の−は4.0〜5.
5の範囲にある。この声調IIK使用する酸は特に限定
されるものではなく無機酸でも有機酸でもよいが、なる
べくおだやかなものがよく、たとえは酢酸などが好適で
ある。
It is best to set the particle size to 4.0 to 5.
It is in the range of 5. The acid used in this tone IIK is not particularly limited and may be an inorganic acid or an organic acid, but it is preferably as mild as possible, for example acetic acid is preferred.

本工程で生成した粒子は系の温度をゼラチンのrル化温
度以下に下げても消失しないので母液との平衡関係はな
い。また、ゼラチンと水溶性多糖類との混合比にもよる
が、粒子はほとんどの場合正に帯電しており、その表面
にはポリメタリン酸イオンが配向していていわゆる電気
二重層を形成している。そして、このことが粒子の安定
な分散を促しているのである。
The particles produced in this step do not disappear even if the temperature of the system is lowered below the gelatinization temperature, so there is no equilibrium relationship with the mother liquor. Furthermore, although it depends on the mixing ratio of gelatin and water-soluble polysaccharide, the particles are almost always positively charged, and polymetaphosphate ions are oriented on their surfaces, forming a so-called electric double layer. . This also promotes stable dispersion of particles.

本発明においては酸を添加して粒子を生成させたのちに
粒子生成液を10℃以下に冷却し、そのことによって界
面活性剤の添加を不要にしたところに特徴がある。冷却
は酸の添加終了後速かに行なう0がよい。添加終了後室
温に放置しておくと粒子が互いに衝突して凝集がはじま
ってし唖う。
The present invention is characterized in that after adding an acid to generate particles, the particle generation liquid is cooled to 10° C. or lower, thereby eliminating the need for adding a surfactant. It is preferable that the cooling be carried out immediately after the addition of the acid is completed. If the mixture is left at room temperature after addition, the particles will collide with each other and begin to aggregate.

温度は10℃以下であるが、5℃以下にすることが好ま
しい。粒子生成後は粒子をアルデヒド系架橋剤で不溶化
するのであるが、その間も粒子分散液を10℃以下に保
つ必要がある。但し、粒子の再分散が容易になる程度に
不溶化が遂行するまでこの温度に保てばよい。
The temperature is 10°C or lower, preferably 5°C or lower. After particle generation, the particles are insolubilized with an aldehyde crosslinking agent, and during this time it is necessary to maintain the particle dispersion at a temperature of 10° C. or lower. However, it is sufficient to maintain this temperature until insolubilization has been achieved to the extent that particles can be easily redispersed.

アルデヒド系架橋剤の添加量はゼラチン乾燥重量の0.
1〜200チ程度であり、添加後は一夜程度放置して架
橋反応を充分に行なわせる。架橋剤の例としては、グル
タルアルデヒド、ホルムアルデヒド、グリオキザール、
クロトンアルデヒド、アクロレイン、アセトアルデヒド
などを挙ケルコとができるが、特にグルタルアルデヒド
が好適である。
The amount of aldehyde crosslinking agent added is 0.00% of the dry weight of gelatin.
The amount is about 1 to 200 mm, and after addition, it is left to stand for about one night to allow the crosslinking reaction to occur sufficiently. Examples of crosslinking agents include glutaraldehyde, formaldehyde, glyoxal,
Examples include crotonaldehyde, acrolein, acetaldehyde, etc., with glutaraldehyde being particularly preferred.

アルデヒド系加橋剤で処理後は粒子を遠心分離等で回収
して洗浄する。洗浄は0.001〜0.01チ程度の陰
イオン系界面活性剤水溶液または0.01〜0,1チの
非イオン系界面活性剤水溶液を用いて2〜3回行なえば
よい。
After treatment with an aldehyde-based crosslinking agent, the particles are collected by centrifugation or the like and washed. Washing may be carried out 2 to 3 times using an aqueous solution of an anionic surfactant of about 0.001 to 0.01 inch or an aqueous solution of a nonionic surfactant of about 0.01 to 0.1 inch.

このようにして得られた担体を種々の用途に供すればよ
いが、架橋が不充分な場合には塩類溶液中で膨潤するこ
とがある。そこでこのような用途に用いる場合にはアル
デヒド系架橋剤で処理して膨潤を防止するのがよい。例
えば、抗原を感作する場合にはり/酸緩衝液中で行なう
ので、赤血球を固定化する条件でホルマリン処理する。
The carrier thus obtained may be used for various purposes, but if crosslinking is insufficient, it may swell in a salt solution. Therefore, when used for such purposes, it is recommended to treat with an aldehyde crosslinking agent to prevent swelling. For example, when sensitizing an antigen, it is carried out in a gel/acid buffer, so formalin treatment is performed under conditions that fix red blood cells.

この処理によって膨潤を防止するとともにホルマリンの
殺菌効果によって長期間の保存に耐える担体が得られる
This treatment prevents swelling and provides a carrier that can withstand long-term storage due to the sterilizing effect of formalin.

本発明の担体は抗原、抗体、酵素などを巾広く固定する
ことができる。たとえば、抗原とか抗体を感作する場合
には動物赤血球を担体として行なう常法に準じて行えば
よい。
The carrier of the present invention can immobilize a wide variety of antigens, antibodies, enzymes, and the like. For example, when sensitizing an antigen or antibody, a conventional method using animal red blood cells as a carrier may be used.

本発明の担体は間接受身凝集反応の担体として従来量も
寸ぐれているとされていた動物赤血球と同等な性能を有
し、さらに化学的、物理的に均質かつ安定であり、抗原
活性がなく任意の粒径のものを容易かつ安価に大量生産
できるなど動物赤血球にない幾多の利点を有するもので
ある。そして、本発明は先願発明に比し、粒子生成後こ
の粒子を不溶化するまでの時期を冷却することによって
界面活性剤を不要にしたものであ、る。従って、本発明
はたとえば界面活性剤の存在を嫌うような用途に担体を
用いる場合に特に威力を発゛揮する。
The carrier of the present invention has performance equivalent to that of animal red blood cells, which was previously thought to be insufficient in quantity, as a carrier for indirect passive agglutination reactions, and is chemically and physically homogeneous and stable, and has no antigenic activity. It has many advantages over animal red blood cells, such as the ability to easily and inexpensively mass-produce particles of any particle size. Further, the present invention, as compared to the prior invention, eliminates the need for a surfactant by cooling the particles after they are generated until they are insolubilized. Therefore, the present invention is particularly effective when the carrier is used in applications where the presence of a surfactant is undesirable, for example.

以下、実施例及び担体の使用例を示す。なお、本明細書
において特に記載がなければ%は重量%を表わしている
Examples and usage examples of carriers are shown below. In this specification, unless otherwise specified, % represents weight %.

実施例1 等電点がP)(9であるゼラチン4fを40℃の温水に
10(1+/!になるように溶解し、10チの水酸化ナ
トリウム溶液を用いてP)(9に調整した。アラビアゴ
ム4fを100m/になるように水に溶解し、不溶物を
r側稜40℃に加温した。
Example 1 Gelatin 4F, whose isoelectric point is P) (9), was dissolved in warm water at 40°C to a concentration of 10 (1+/!), and adjusted to P) (9) using a 10T sodium hydroxide solution. 4f of gum arabic was dissolved in water to a concentration of 100 m/g, and the insoluble matter was heated to 40°C on the r side edge.

上記のゼラチン溶液50ffizおよびアラビアゴム溶
液5(it/!を混合し、これに30容量チエチルアル
コール溶液300ml、 1’0 %へキサメタリン酸
ナトリウム溶液1.5ml、および1チリアクテイブレ
ツド溶液6ゴを加えてよく攪拌し、全体を40℃に加温
した2 次いで、この混合液を攪拌しなから10容量チの酢酸溶
液を滴下してPH5,0に調整した。
Mix 50 ffiz of the above gelatin solution and 5 g of gum arabic solution (it/!), add 300 ml of 30 volume thiethyl alcohol solution, 1.5 ml of 1'0% sodium hexametaphosphate solution, and 6 g of 1 titanium lactate solution. was added, stirred thoroughly, and the whole was heated to 40°C.Next, 10 volumes of acetic acid solution was added dropwise to the mixture while stirring to adjust the pH to 5.0.

::・。::・.

一調整により生成した粒子分散液を水浴中でただちに5
℃まで冷却し、グルタルアルデヒド1.32を加えた。
Immediately place the particle dispersion produced by one adjustment in a water bath for 50 minutes.
It was cooled to 0.degree. C. and 1.32 g of glutaraldehyde was added.

そして、よく攪拌しだ後5℃で一夜装置した。それから
この粒子分散液を2QQQrpnで10分間遠心分離し
て粒子を(レッドとして回収した。この粒子を0.00
5%のアルキルスルホマレイン酸(デモールE、花王石
鹸株)登録商標)溶液に@濁して遠心分離する洗浄操作
を3回繰返してから4容t%ホルマリン溶液に分散し、
5℃で1週間静置した。
After stirring well, the mixture was kept at 5° C. overnight. Then, this particle dispersion was centrifuged for 10 minutes using 2QQQrpn, and the particles were collected as red.
The washing procedure of turbidity and centrifugation was repeated three times in a 5% alkylsulfomaleic acid (Demol E, Kao Soap Co., Ltd. registered trademark) solution, and then dispersed in a 4 volume t% formalin solution.
It was left standing at 5°C for one week.

こうして得られた担体粒子の収量は6.42であり、得
られた粒子の75チは3〜6μの範囲にあった0 実施例2 下記の点を除いて実施例1と同様にして担体粒子を調製
した。
The yield of the carrier particles thus obtained was 6.42, and 75 particles of the obtained particles were in the range of 3 to 6μ. was prepared.

すなわち、まずアラビアゴム4りのかわりにカル〆キン
メチルセルロース12を、そして1チリアクテイブレツ
ド溶液5 mlのかわりに1チダイレクトブルー溶液1
.5 mlを用いた。それから、添加量についてもゼラ
チン、10%へキサメタリン酸す) IJウム溶液、お
よびグルタルアルデヒドをいずれ414分の1にした。
That is, first, instead of 4 parts of gum arabic, 12 parts of calcined methylcellulose, and 1 part of 1 part of Direct Blue solution instead of 5 ml of 1 part of Acty Red solution.
.. 5 ml was used. Also, the amounts of gelatin, 10% hexametaphosphoric acid solution, and glutaraldehyde were reduced to 1/414.

また、酢酸滴下終了−を4.6にしだ。Also, the end of acetic acid addition was set to 4.6.

このようにして得られた担体粒子の収量は4.5fであ
り、得られた粒子の95%が0.8〜1.5μの範囲に
あった。
The yield of carrier particles thus obtained was 4.5f, and 95% of the particles obtained were in the range of 0.8-1.5μ.

実施例3 下記の点を除いて実施例1と同様にして担体粒子を調製
した。
Example 3 Carrier particles were prepared in the same manner as in Example 1 except for the following points.

すなわち、ゼラチン溶液を5omtから40m1にし、
そしてアラビアゴム溶液を50ffi/から6Qmlに
した。それから、10%へキサメタリン酸ナトリウム溶
液を1.6 mlから1.2 mlに、1チリアクテ4
ブレyドロ1R1を1%ダイレクトブルー4.811I
 K 。
That is, the gelatin solution was changed from 5omt to 40ml,
Then, the gum arabic solution was made up from 50ffi/ to 6Qml. Then, from 1.6 ml to 1.2 ml of 10% sodium hexametaphosphate solution, add 1 tiliacte 4
Bray Dro 1R1 1% Direct Blue 4.811I
K.

ソシてグルタルアルデヒドを1.3Fかう1.0PKそ
れぞれ変えた。また、酢酸滴下終了−を4.6とした。
Then, the glutaraldehyde was changed by 1.3F and 1.0PK respectively. Moreover, the end of acetic acid addition was set at 4.6.

本例で得られた担体粒子の収量は7.8fであり、得ら
れた粒子の90%が1〜2μの範囲にあった。
The yield of carrier particles obtained in this example was 7.8f, and 90% of the particles obtained were in the range of 1 to 2μ.

実施例4 下記の点を除いて実施例1と同様にして担体粒子を調製
した、。
Example 4 Carrier particles were prepared in the same manner as in Example 1 except for the following points.

すなわち、ゼラチン溶液を50厘lから6011にし、
アラビアゴム溶液を50+u/から4Qntlに変えた
。それから、10%へキサメタリン酸ナトリウム溶液を
1.6 R1から2111tに、1チリアクテイプレ7
ド5 mlを1チダイレクトブルー7.2 mlに、そ
してグルタルアルデヒドを132から1.8gにそれぞ
れ変えた。また、酢酸滴下終了−を4.8とした。
That is, the gelatin solution was changed from 50 liters to 6011,
The gum arabic solution was changed from 50+u/ to 4Qntl. Then add 10% sodium hexametaphosphate solution to 1.6
The amount of glutaraldehyde was changed from 5 ml to 7.2 ml of 1-tidirect blue, and from 132 to 1.8 g of glutaraldehyde. In addition, the completion of acetic acid addition was set at 4.8.

本例で得られた担体粒子の収量は9.6ノであり、得ら
れた粒子の75チが3〜6μの範囲にあった。
The yield of carrier particles obtained in this example was 9.6 mm, and 75 particles of the obtained particles were in the range of 3 to 6 microns.

使用例1 実施例1で得られた担体粒子を濃度が1%になるように
pH7,2のリン酸塩緩衝生理食塩水(以下、PBSと
略記する。)に分散し、その5dを5 ppmのタンニ
ン酸を含むPH7,2のPBS 5 yrlと混合した
Usage Example 1 The carrier particles obtained in Example 1 were dispersed in phosphate buffered saline (hereinafter abbreviated as PBS) of pH 7.2 to a concentration of 1%, and the 5d was dispersed at 5 ppm. of PBS 5 yrl, pH 7.2, containing tannic acid.

混合液を37℃で15分間加温後遠心分離して、生理食
塩水で充分洗浄してからL%になるようにpH7,2の
PH85mlに分散した0、一方、高純1iKff製し
たストレプトキナーゼを32 UAIになるようにP)
(7,2のPBSに溶解した。
The mixed solution was heated at 37°C for 15 minutes, centrifuged, thoroughly washed with physiological saline, and then dispersed in 85 ml of pH 7.2 to give a concentration of 0 and 1 iKff streptokinase. P) to be 32 UAI
(Dissolved in 7,2 PBS.

タンニン酸処理粒子分散液5 mlとストレプトキナー
ゼ溶液5 mlとを混合し、37℃で30分間加温した
。その後、粒子を遠心分離して生理食塩水で3回洗浄し
、濃度が5チになるように分散用メディウムに分散して
凍結乾燥した。
5 ml of the tannic acid-treated particle dispersion and 5 ml of the streptokinase solution were mixed and heated at 37° C. for 30 minutes. Thereafter, the particles were centrifuged, washed three times with physiological saline, dispersed in a dispersion medium to a concentration of 5%, and freeze-dried.

このようにして得られたストレゾトキナービ固定化粒子
の力価をマイクロプレート法によって求めた。結果を下
表に示す。
The titer of the Strezotokinabi-immobilized particles thus obtained was determined by a microplate method. The results are shown in the table below.

特許出願人 富士臓器製薬株式会社 代理人 弁理士 1)中 政 浩Patent applicant: Fuji Organ Pharmaceutical Co., Ltd. Agent Patent Attorney 1) Masahiro Naka

Claims (1)

【特許請求の範囲】[Claims] ゼラテ/、水溶性多糖類、ポリメタリン酸プトリウム、
親水性有機溶媒、および水を含み、温度がゼラチンのケ
°ル化温度以上である溶液を、攪拌しつつ酸を加えてP
H2,5〜6.0に調整し、ソノ後アルデヒド系架橋剤
を作用せしめて不溶化する人工担体の製法において、前
記酸の添加によって粒子が生成したのちこの粒子分散液
をIOC以下に冷却し、10℃以下の温度で前記架橋剤
を作用せ1−めることを特徴とする人工担体の製法。
gelate/, water-soluble polysaccharide, polymetaphosphate,
A solution containing a hydrophilic organic solvent and water and having a temperature higher than the gelatin gelatin temperature is heated by adding an acid while stirring.
In the method for manufacturing an artificial carrier in which H2 is adjusted to 5 to 6.0 and insolubilized by applying an aldehyde crosslinking agent after sonication, particles are generated by the addition of the acid, and then the particle dispersion is cooled to below IOC, 1. A method for producing an artificial carrier, characterized in that the crosslinking agent is applied at a temperature of 10° C. or lower.
JP20986981A 1981-03-18 1981-12-28 Production of artificial carrier Granted JPS58113755A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP20986981A JPS58113755A (en) 1981-12-28 1981-12-28 Production of artificial carrier
EP19820301235 EP0062968B2 (en) 1981-03-18 1982-03-11 Support material for use in serological testing and process for the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20986981A JPS58113755A (en) 1981-12-28 1981-12-28 Production of artificial carrier

Publications (2)

Publication Number Publication Date
JPS58113755A true JPS58113755A (en) 1983-07-06
JPS6332148B2 JPS6332148B2 (en) 1988-06-28

Family

ID=16579977

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20986981A Granted JPS58113755A (en) 1981-03-18 1981-12-28 Production of artificial carrier

Country Status (1)

Country Link
JP (1) JPS58113755A (en)

Also Published As

Publication number Publication date
JPS6332148B2 (en) 1988-06-28

Similar Documents

Publication Publication Date Title
US4416813A (en) Artificial carrier for immobilization of biological proteins
US4671954A (en) Microspheres for incorporation of therapeutic substances and methods of preparation thereof
Wood Jr et al. The inhibition of surface phagocytosis by the capsular" slime layer" of pneumococcus type III
JPS5816693A (en) Production of substance produced by bacteria
JPS59501213A (en) Crystallized carbohydrate matrices for biologically active substances, methods of producing the matrices, and uses thereof
US5144008A (en) Artificial carrier for immobilization of biological proteins
CN109044963B (en) A kind of preparation method of the nano-hydrogel of injection pH sensibility
CN101308140B (en) Concealed malachite green gold mark detection test paper box and method for making same
JPH0317103B2 (en)
DE1961541A1 (en) Immunological indicator reagent
JPS60130601A (en) Manufacture of hyaluronic acid water-insoluble composition
JPS58113755A (en) Production of artificial carrier
EP0062968B2 (en) Support material for use in serological testing and process for the production thereof
JPH0317303B2 (en)
CN103980717A (en) Gelatin-natural polysaccharide blending modified capsule
JPS58113757A (en) Manufacture of artificial carrier
JPS6329223B2 (en)
JPS58113754A (en) Production of artificial carrier
JPS6332146B2 (en)
JPS58113756A (en) Production of artificial carrier
JPS5935143A (en) Carrier for immobilizing actic protein
RU2326655C1 (en) Method of incapsulation of protein bearing materials in microspheres from copolymer polylactide-polyglycolide
Vural et al. Cyclophosphamide loaded albumin microspheres II. Release characteristics
JPS6067417A (en) Production of microcapsules metabolizable in vivo
DE1806418A1 (en) Protein-like reagent and manufacturing process therefor

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term
S199 Written request for registration of transfer of right

Free format text: JAPANESE INTERMEDIATE CODE: R313199

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370